Jubilant co to sell stake in US firm for $139 million – Times of India
NEW DELHI: Jubilant Pharmova’s subsidiary Jubilant Pharma will sell its entire 25.8% stake in US-based Sofie Biosciences for $139.4 million. Singapore-based Jubilant Pharma invested $25 million in Sofie in November 2020, says a company statement.Sofie is engaged in developing and delivering molecular diagnostics and therapeutics (theranostics). It has radiopharmaceutical production and distribution network, mature contract…
